triiodothyronine has been researched along with No-Reflow Phenomenon in 1 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Madak, N | 1 |
| Nazlı, Y | 1 |
| Mergen, H | 1 |
| Aysel, S | 1 |
| Kandaz, M | 1 |
| Yanık, E | 1 |
| Cekdemir, D | 1 |
| Tavlı, T | 1 |
1 other study available for triiodothyronine and No-Reflow Phenomenon
| Article | Year |
|---|---|
Acute phase reactants in patients with coronary slow flow phenomenon.
Topics: Aged; C-Reactive Protein; Coronary Angiography; Coronary Circulation; Cross-Sectional Studies; Femal | 2010 |